FDA 执法报告 D-0106-2027:Eagle Pharma 催产素 500 mL 产品因无菌保障不足被列为 II 级召回
FDA drug enforcement D-0106-2027: Eagle Pharma Outsourcing LLC — Lack of Assurance of Sterility
FDA 执法报告 D-0106-2027 显示,Eagle Pharma Outsourcing LLC 的催产素 30 USP 单位加入 0.9% 氯化钠 500 mL 单次使用容器产品因无菌保障不足被列为 II 级召回。
记录列出了该产品召回的分级、批号与分销范围,可用于核对产品标识及召回状态口径。
FDA 药品召回执法报告 — D-0106-2027
报告发布日期:2026-11-04。这是执法报告日期,不是召回启动日期。
范围:一条已分类的药品召回记录;event_id 可能归组多个产品。无召回编号的未分类记录不在本数据流范围内。本记录不是新闻稿,也不是新的执法认定。
openFDA 数据集每周更新。报告状态不是实时召回状态,不得用于跟踪召回生命周期。以下其他日期保留其各自名称所对应的含义。
完整的官方产品记录(包括 openFDA 统一标识符):
{
"address_1": "2200 Riverchase Ctr Ste 675",
"address_2": "",
"center_classification_date": "20261028",
"city": "Hoover",
"classification": "Class II",
"code_info": "Lot: OXY30-1006, Expiry: 10/10/2026.",
"country": "United States",
"distribution_pattern": "Nationwide within the U.S",
"event_id": "100073",
"initial_firm_notification": "E-Mail",
"more_code_info": "",
"openfda": {},
"postal_code": "35244-2918",
"product_description": "OXYTOCIN, 30 USP UNITS, Added to 0.9% Sodium Chloride 500 mL - Single-Use Container, Rx Only, EAGLE PHARMA OUTSOURCING, 2200 Riverchase Center, Suite 675, Hoover, AL 35244, UPC: 6985203050. NDC 69852-030-50",
"product_quantity": "5 500-mL containers",
"product_type": "Drugs",
"reason_for_recall": "Lack of Assurance of Sterility",
"recall_initiation_date": "20261008",
"recall_number": "D-0106-2027",
"recalling_firm": "Eagle Pharma Outsourcing LLC",
"report_date": "20261104",
"state": "AL",
"status": "Ongoing",
"voluntary_mandated": "Voluntary: Firm initiated"
}
来源:openFDA 已分级药品召回执法报告 · api.fda.gov